Interstitial fibrosis and angiotensin-converting enzyme inhibition in patients with end-stage myocardial infarction.
Volders
P G
PG
Daemen
M J
MJ
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D006332:Cardiomegaly / Q000473:pathology; D002921:Cicatrix / Q000473:pathology; D004108:Dilatation, Pathologic / Q000473:pathology; D004719:Endomyocardial Fibrosis / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy
D000806:Angiotensin-Converting Enzyme Inhibitors